Skip to content

Prevalence of H. Pylori Gastritis in Sleeve Gastrectomy Specimens

Prevalence of H. Pylori Gastritis in Sleeve Gastrectomy Specimens: A Cross-Sectional

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05101395
Enrollment
810
Registered
2021-11-01
Start date
2015-01-01
Completion date
2019-10-30
Last updated
2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastritis, Gastritis H Pylori, Obesity Associated Disorder

Keywords

Histopathology, Sleeve gastrectomy, LSG, Gastritis, H. Pylori, Jordan, Middle East

Brief summary

This is a cross-sectional study looking for prevalence of H.Pylori related gastritis among patients underwent sleeve gastrectomy over five year study period. The study also looks for possible association with patients's characteristics. Also, compares its findings with similar regional and international studies.

Interventions

Giemsa special stain was employed for detection of H. Pylori microorganisms.

Sponsors

University of Jordan
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
12 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients who underwent sleeve gastrectomy * surgery was performed between January 2015 and October 2019

Exclusion criteria

* patients whose resected specimens were not examined histopathologically

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of gastritisstart to end of the study, 5 yearsproportion of patients who underwent sleeve gastrectomy who have gastritis in their resected gastric specimen at or during study period. calculated as (number of pt with gastritis / number of examined resected gastric specimens)
Prevalence of H.pylori gastritisstart to end of the study, 5 yearsproportion of patients who underwent sleeve gastrectomy who have H.pylori related gastritis in their resected gastric specimen at or during study period. calculated as (number of pt with H.pylori gastritis / number of examined resected gastric specimens)

Secondary

MeasureTime frameDescription
Prevalence of other histopathological findingsstart to end of the study, 5 yearsproportion of patients who underwent sleeve gastrectomy who have histopathological findings not including gastritis or H.pylori related gastritis in their resected gastric specimen at or during study period. calculated as (number of pt with the histopathological finding / number of examined resected gastric specimens)
likelihood ratio between H.pylori gastritis and advancing agestart to end of the study, 5 yearsThe relationship between H.pylori gastritis and advancing age. likelihood ratio will be calculated by cross table analysis using Statistical Analysis Software SPSS program version 26.
likelihood ratio between H.pylori gastritis and female genderstart to end of the study, 5 yearsThe relationship between H.pylori gastritis and female gender. likelihood ratio will be calculated by cross table analysis using Statistical Analysis Software SPSS program version 26.
likelihood ratio between H.pylori gastritis and BMIstart to end of the study, 5 yearsThe relationship between H.pylori gastritis and body mass index (BMI). weight and height will be combined to report BMI in kg/m\^2 likelihood ratio will be calculated by cross table analysis looking for using Statistical Analysis Software SPSS program version 26.

Countries

Jordan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026